Gene interactions and pathways from curated databases and text-mining

◀ Back to PRKAB2

PRKAB2 — SREBF1

Pathways - manually collected, often from reviews:

Text-mined interactions from Literome

Zhou et al., J Clin Invest 2001 (Diabetes Mellitus, Type 2) : Activation of AMPK by metformin or an adenosine analogue suppresses expression of SREBP-1 , a key lipogenic transcription factor
You et al., Gastroenterology 2004 (Fatty Liver, Alcoholic...) : Moreover, activation of AMPK by metformin or AICAR largely blocked the ability of ethanol to increase levels of mature SREBP-1 protein
Kohjima et al., Int J Mol Med 2008 (Fatty Liver) : It is known that SREBP-1c is negatively regulated by AMP activated protein kinase (AMPK) but expression levels of AMPK in NAFLD were almost equal to those of the controls
Park et al., Hepatology 2008 (Carcinoma, Hepatocellular...) : ALA increased AMPK phosphorylation in the liver and in cultured liver cells, and dominant negative AMPK partially prevented ALA induced suppression of insulin stimulated SREBP-1c expression
Yang et al., J Cell Biochem 2009 : It has long been documented that AMPK activation suppresses hepatic SREBP-1 mRNA and nuclear SREBP-1 protein ... We found that AMPK is robustly activated in rat hepatoma McA-RH7777 cells treated with two widely used AMPK activators, AICAR and metformin, and AMPK activation sharply suppresses SREBP-1c mRNA and nuclear SREBP-1c protein, but not SREBP-1a mRNA derived from the same gene ... AMPK does not enhance SREBP-1c mRNA degradation in the presence of the general transcription inhibitor actinomycin D ; instead it inhibits SREBP-1c promoter activity in a luciferase reporter assay ... AMPK mediated inhibition of SREBP-1c promoter activity can also be abrogated by the AMPK inhibitor Compound C ... Furthermore AMPK activation significantly attenuates the synthetic liver X receptor ( LXR ) ligand T0901317 induced SREBP-1c promoter activity ... We conclude that AMPK suppresses hepatic SREBP-1c mRNA expression by inhibiting LXR dependent SREBP-1c transcription via inhibition of endogenous LXR ligand production and by inhibiting SREBP-1c processing in McA-RH7777 cells
Kim et al., J Agric Food Chem 2009 (Carcinoma, Hepatocellular...) : Taken together, AMPK mediates CK induced suppression and activation of SREBP1c and PPAR-alpha, respectively, and these effects seem to be one of antidiabetic and/or antihyperlipidemic mechanisms of CK in insulin-resistant HepG2 human hepatoma cells
Li et al., Cell Metab 2011 (Atherosclerosis...) : AMPK stimulates Ser372 phosphorylation, suppresses SREBP-1c cleavage and nuclear translocation, and represses SREBP-1c target gene expression in hepatocytes exposed to high glucose, leading to reduced lipogenesis and lipid accumulation
Jung et al., J Lipid Res 2011 (Fatty Liver) : OA-induced SREBP-1 transcriptional activity was suppressed by cotreatment with aminoimidazole carboxamide ribonucleotide ( AICAR ) or metformin, or by overexpression of constitutively active AMPK ( CA-AMPK ) in the human hepatoma cell line
Hu et al., Hepatology 2012 (Fatty Liver, Alcoholic) : CONCLUSION : In conclusion, ethanol induced up-regulation of lipin-1 gene expression is mediated through inhibition of AMPK and activation of SREBP-1
Pil Hwang et al., Mol Nutr Food Res 2013 : These results indicate that CDCQ prevented lipid accumulation by blocking the expression of SREBP-1c and FAS through LKB1/SIRT1 and AMPK activation in HepG2 cells, suggesting that CDCQ plays a potential role in the prevention of lipogenesis by AMPK activation
Quan et al., Biochem Pharmacol 2013 (Fatty Liver) : We found that BA activates AMPK via phosphorylation, suppresses SREBP1 mRNA expression, nuclear translocation and repressed SREBP1 target gene expression in HepG2 cells and primary hepatocytes, leading to reduced lipogenesis and lipid accumulation
Hwang et al., Food Chem 2013 : Moreover, the use of a pharmacological AMPK inhibitor revealed that AMPK is essential for the suppression of SREBP-1c expression in CKS treated cells
Jin et al., Toxicol Appl Pharmacol 2013 : We found that the ability of resveratrol to repress T0901317 induced SREBP-1c expression was not dependent on AMPK and Sirt1